InvestorsHub Logo
Followers 0
Posts 1151
Boards Moderated 0
Alias Born 07/10/2003

Re: SlopsterSlasher post# 16730

Sunday, 08/15/2004 7:41:46 AM

Sunday, August 15, 2004 7:41:46 AM

Post# of 82595
I think Genaissance is far behind Dnap because of the way the CEO talks about their progress. Just this past march 2003 they were talking about gene association with ony 3 statnomes {Atorvastatin ; Provastatin ; Simvastatin} over a 16 week trial {thats nothing} by project name Strength Study.Where Dnap From the first Newsletter: Aug 17,2001

OTHER TESTS - We have finished both the genotyping and the computational screening for Lipitor and Zocor, and we have finished the genotyping but not the computational screening for about 15 other drugs we have good sample sizes for. As we complete these projects, we will disclose the results within a formal, peer-reviewed setting such as a professional meeting or in the scientific literature. AND At present our scientists have completed the screen of the xenobiotic genome for the Statnome project and are validating the performance of the resulting classifier. It is clear that Dnap is far ahead of the pack.